Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 3
1995 1
1996 2
1997 3
1999 7
2000 2
2001 6
2002 7
2003 5
2004 12
2005 5
2006 4
2007 10
2008 10
2009 8
2010 11
2011 7
2012 7
2013 3
2014 6
2015 2
2016 1
2017 2
2020 2
2021 4
2022 6
2023 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 19117692

120 results

Results by year

Filters applied: . Clear all
Page 1
Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer.
Citrin D, Mansueti J, Likhacheva A, Sciuto L, Albert PS, Rudy SF, Cooley-Zgela T, Cotrim A, Solomon B, Colevas AD, Russo A, Morris JC, Herscher L, Smith S, Van Waes C. Citrin D, et al. Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1040-6. doi: 10.1016/j.ijrobp.2008.09.053. Epub 2008 Dec 29. Int J Radiat Oncol Biol Phys. 2009. PMID: 19117692 Free PMC article.
Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol.
Abitbol A, Abdel-Wahab M, Lewin A, Troner M, Rodrigues MA, Hamilton-Nelson KL, Markoe A. Abitbol A, et al. Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):942-7. doi: 10.1016/s0360-3016(02)02816-x. Int J Radiat Oncol Biol Phys. 2002. PMID: 12095561 Clinical Trial.
The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
Suntharalingam M, Jaboin J, Taylor R, Wolf J, Banglore M, Van Echo D, Ord R. Suntharalingam M, et al. Semin Oncol. 2004 Dec;31(6 Suppl 18):2-7. doi: 10.1053/j.seminoncol.2005.02.001. Semin Oncol. 2004. PMID: 15726515 Clinical Trial.
Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neck.
Rosenthal DI, Lee JH, Sinard R, Yardley DA, Machtay M, Rosen DM, Egorin MJ, Weber RS, Weinstein GS, Chalian AA, Miller LK, Frenkel EP, Carbone DP. Rosenthal DI, et al. J Clin Oncol. 2001 Mar 1;19(5):1363-73. doi: 10.1200/JCO.2001.19.5.1363. J Clin Oncol. 2001. PMID: 11230480 Clinical Trial.
Induction paclitaxel, carboplatin, and infusional 5-FU followed by concurrent radiation therapy and weekly paclitaxel/carboplatin in the treatment of locally advanced head and neck cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD, Meluch AA, McClurkan S, Gray JR, Stroup SL, Burris HA 3rd, Yardley DA, Bradof JE, Yost K, Ellis JK, Greco FA. Hainsworth JD, et al. Cancer J. 2002 Jul-Aug;8(4):311-21. doi: 10.1097/00130404-200207000-00007. Cancer J. 2002. PMID: 12184409 Clinical Trial.
120 results